Tex. Ins. Code § 1379.052 · Subchapter B. COVERAGE FOR ROUTINE PATIENT CARE COSTS
COVERAGE REQUIRED.
Text — Current through the 89th 2nd Called Legislative Session, 2025
A health benefit plan issuer shall provide benefits for routine patient care costs to an enrollee in connection with a phase I, phase II, phase III, or phase IV clinical trial if the clinical trial is conducted in relation to the prevention, detection, or treatment of a life-threatening disease or condition and is approved by:
(1) the Centers for Disease Control and Prevention of the United States Department of Health and Human Services;
(2) the National Institutes of Health;
(3) the United States Food and Drug Administration;
(4) the United States Department of Defense;
(5) the United States Department of Veterans Affairs; or
(6) an institutional review board of an institution in this state that has an agreement with the Office for Human Research Protections of the United States Department of Health and Human Services.
Notes and commentary — not statutory text
History
Added by Acts 2009, 81st Leg., R.S., Ch. 719 (S.B. 39), Sec. 1, eff. September 1, 2009.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/IN/htm/IN.1379.htm
- Text hash
- sha256 11817625ec212a64f7f569923f8b8f7968b4dbac16a2cbad1325ec711a24b6c6
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Cited by 1 provision
Provisions in this library whose text cites Tex. Ins. Code § 1379.052. Each shows the citation as that text prints it.
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.